Pharmacovigilance: The inside track

Sue Overton, MUS Team Administrator, Medicines Use and Safety (SPS)Event 13 October 2021Location Online
Topics: Past EventsRegulatory

The webinar discussed the process for reporting and monitoring pharmacovigilance for post-marketing medicines


13 October 2021



About the event

The webinar explained pharmacovigilance (PV) and its impact on everyday practice.

Why it’s important

It’s important to understand the process of PV to ensure medication events are reported.

What was covered

The webinar covered:

  • An outline of what PV is and its aims.
  • The importance of reporting and communication was discussed, as well as what happens when we make e.g. yellow card reports to the MHRA.
  • Future developments of the system and other initiatives such as genomics.


A range of speakers ran this event from SPS and other organisations.

SPS Speakers

Learn more about SPS team member who are speaking.

Non-SPS speakers

Mitul Jadeja

Special Projects Manager, Vigilance Intelligence and Research.
Vigilance and Risk Management of Medicines (VRMM), MHRA


Access the recording of the webinar

Contact us

Contact the Admin Team if you have any questions